Together: Transforming and Translating Discovery to Improve Health

联系PD/PI：Nelson，David R 摘要：UF临床与翻译科学奖：总体 UF CTSI的使命是通过加速科学发现的转化来改善人类健康 以及实施以证据为基础的最佳做法，以诊断、治疗、预防和治愈 人类疾病。CTSI将追求四个总体战略目标，以推进其愿景，每个目标都与 计划和里程碑。战略目标1：规划发展翻译服务的新途径 劳动力。CTSI正在重塑翻译研究职业的途径和支持机制 通过其新的跨学科、以能力为基础的培训和专业发展方案； 与社区和历史上的黑人学院和大学建立伙伴关系，以加强多样性；以及独特 团队科学学习机会和环境，将所有学科和卫生专业聚集在一起 以丰富UF和整个CTSA网络的翻译员工队伍。战略目标2：嵌入 翻译科学贯穿于密歇根大学的学习健康系统，以支持连续的探索循环， 创新，落实。CTSI开发了变革性的基础设施和翻译 整合UF临床和研究企业的科学计划，形成具有凝聚力的学习健康 系统。CTSI和UF Health将建立在强大的翻译科学基础上，以开发高级数据 在研究和病人护理的交叉点上的能力和卓越的工作环境，扩大 高影响力的试点方案，将发现和研究转化为多样化的医疗保健 不断开创分子医学临床实施的先河。战略目标3：扩张 全州范围内的合作和机会，以推进以参与者为中心的研究议程 反映了佛罗里达州1990万人的健康优先事项和多样性。CTSI及其社区 研究伙伴，佛罗里达州立大学，已经制定了全州范围的计划和合作，并有一个愿景 确保所有佛罗里达人都有发言权和机会参与研究--包括社区 成员、患者、护理人员、临床医生、政策制定者、付款人和其他利益相关者。CTSI将会起作用 与其合作伙伴整合和扩展全州研究基础设施和协作，以更好地参与 并通过翻译科学为佛罗里达州的社区服务，并将佛罗里达州发展为典范、合作伙伴和 研究和解决更多样化和老年美国人口的医疗保健需求的目的地。 战略目标4：加快CTSA网络的集体影响。CTSI将与 CTSA在多方向开发、评估、传播和实施新的 提高翻译研究质量和效率的方法和流程。CTSI将 通过其在多地点学习支持、招聘方法和实践方面的优势实现这一目标 特殊人群的保留，以及新的临床代谢组学和网络科学计划。 项目摘要/摘要页303 联系PD/PI：Nelson，David R

Contact PD/PI: Nelson, David R Abstract: UF Clinical and Translational Science Award: Overall The mission of the UF CTSI is to improve human health by accelerating the translation of scientific discoveries and the implementation of evidence-based best practices for the diagnosis, treatment, prevention and cure of human disease. The CTSI will pursue four overarching strategic goals to advance its vision, each with related initiatives and milestones. Strategic Goal 1: Chart new pathways for developing the translational workforce. The CTSI is reshaping the pathways and support mechanisms for translational research careers through its novel interdisciplinary, competency-based training and professional development programs; partnerships with communities and historically black colleges and universities to enhance diversity; and unique team science learning opportunities and environments that bring together all disciplines and health professions to enrich the translational workforce at UF and across the CTSA network. Strategic Goal 2: Embed translational science throughout UF’s learning health system to support a continuous cycle of inquiry, innovation, and implementation. The CTSI has developed transformative infrastructure and translational science programs that integrate UF’s clinical and research enterprises to form a cohesive learning health system. The CTSI and UF Health will build on a strong translational science base to develop advanced data capabilities and an outstanding environment for work at the intersection of research and patient care, expand high-impact pilot programs to transform discovery and the translation of research to diverse health care settings, and continue to pioneer the clinical implementation of molecular medicine. Strategic Goal 3: Expand statewide collaborations and opportunities to advance a participant-centered research agenda that reflects the health priorities and diversity of Florida’s 19.9M people. The CTSI and its community research partner, Florida State University, have developed statewide programs and collaborations with a vision of ensuring all Floridians have a voice and opportunity to participate in research – including community members, patients, caregivers, clinicians, policymakers, payers, and other stakeholders. The CTSI will work with its partners to integrate and expand statewide research infrastructure and collaborations to better engage and serve Florida's communities through translational science, and to develop Florida as a model, partner, and destination for studying and addressing the health care needs of a more diverse and older US population. Strategic Goal 4: Accelerate the collective impact of the CTSA network. The CTSI will collaborate with other CTSA hubs in the multi-directional development, evaluation, dissemination, and implementation of new methods and processes for improving the quality and efficiency of translational research. The CTSI will accomplish this through its strengths in multisite study support, the methods and practice of recruitment and retention of special populations, and novel clinical metabolomics and network science programs. Project Summary/Abstract Page 303 Contact PD/PI: Nelson, David R